PRTA
Prothena Corporation PLC
Price:  
14.05 
USD
Volume:  
294,345.00
Ireland | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PRTA EV/EBITDA

-279.7%
Upside

As of 2025-02-10, the EV/EBITDA ratio of Prothena Corporation PLC (PRTA) is -1.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRTA's latest enterprise value is 236.77 mil USD. PRTA's TTM EBITDA according to its financial statements is -167.68 mil USD. Dividing these 2 quantities gives us the above PRTA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.3x - 13.9x 10.4x
Forward P/E multiples 9.6x - 16.7x 12.0x
Fair Price (20.26) - (33.66) (25.25)
Upside -244.2% - -339.6% -279.7%
14.05 USD
Stock Price
(25.25) USD
Fair Price

PRTA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-07 -1.41
2025-02-06 -1.54
2025-02-05 -1.65
2025-02-04 -1.55
2025-02-03 -1.22
2025-01-31 -1.47
2025-01-30 -1.62
2025-01-29 -1.98
2025-01-28 -2.02
2025-01-27 -2.05
2025-01-24 -1.92
2025-01-23 -1.87
2025-01-22 -1.53
2025-01-21 -1.43
2025-01-17 -1.32
2025-01-16 -1.13
2025-01-15 -1.16
2025-01-14 -0.97
2025-01-13 -1.12
2025-01-10 -1.09
2025-01-08 -1.45
2025-01-07 -1.44
2025-01-06 -1.12
2025-01-03 -1.35
2025-01-02 -1.29
2024-12-31 -1.35
2024-12-30 -1.68
2024-12-27 -1.76
2024-12-26 -1.95
2024-12-24 -1.85
2024-12-23 -1.82
2024-12-20 -1.79
2024-12-19 -2.04
2024-12-18 -0.74
2024-12-17 -1.41
2024-12-16 -0.95
2024-12-13 -1.01
2024-12-12 -1.34
2024-12-11 -1.44
2024-12-10 -1.57
2024-12-09 -1.51
2024-12-06 -1.41
2024-12-05 -1.37
2024-12-04 -1.57
2024-12-03 -1.33
2024-12-02 -1.72
2024-11-29 -2.11
2024-11-27 -2.00
2024-11-26 -1.90
2024-11-25 -1.74